To view this email as a web page, click here

Today's Rundown

Featured Story

With plant-based manufacturing platform, Medicago takes COVID-19 vaccine production into the greenhouse

During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is hoping to repeat that magic with plant-based prophylactics. 

read more

Top Stories

Moderna aims to launch a single-dose COVID-19 vaccine next year in India: report

Moderna plans to launch a single-dose version of its COVID-19 vaccine in India next year and is in discussion with companies in the country to supply it, India's PTI news agency reports. Plus, Pfizer will supply 50 million vaccine doses to India from July to October of this year, the report says.

read more

UPDATED Coronavirus tracker: CDC study finds few breakthrough infections, even fewer hospitalizations

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

read more

Pitt's inhalable 'nanobody' fights off COVID-19 in hamsters at ultralow doses

Existing COVID-19 monoclonal antibodies require high doses to be effective against the disease. Now, scientists at the University of Pittsburg showed that very low doses of a tiny antibody known as a “nanobody,” administered directly through the nose or by inhalation, could prevent and treat severe COVID in hamsters.

read more

COVID-19 tracker: EU investigates death in Belgium after J&J shot; Biden orders probe into Covid origins

The European Union's drug regulator is investigating the death of a woman in Belgium who received J&J's single-dose vaccine and developed a blood clot. President Joe Biden ordered U.S. intelligence to develop a report on COVID-19's origins in 90 days. And more headlines.

read more

Food safety tester Clear Labs raises $60M to chase COVID-19 variants

Clear Labs is looking to put down new roots in the fight against COVID-19 by pivoting its genomic testing tech previously aimed at catching salmonella and listeria before they reach the dinner table.

read more

VillageMD grows its footprint in Houston as COVID-19 shines light on need for accessible primary care

Among the many challenges brought by COVID-19 the pandemic also has shone a spotlight on the importance of primary care providers. Clive Fields, M.D., VillageMD co-founder, details the company's expansion in the Houston market and efforts to increase broad-based, universally accessible primary care.

read more